STAT+: Recursion, the AI drug development company, cuts more jobs after finalizing Exscientia merger

Last week, Recursion Pharmaceuticals, a company utilizing artificial intelligence and machine learning for drug development, laid off employees following a merger. The company is known for its advanced use of technology in the field. To learn more about the details of the layoffs and merger, the full story can be accessed on STAT+.

Source link